Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891900934> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2891900934 endingPage "5495" @default.
- W2891900934 startingPage "5489" @default.
- W2891900934 abstract "Background/Aim: To investigate whether TTF-1 expression predicts a beneficial response of non-squamous non-small-cell lung cancer (NS-NSCLC) patients to bevacizumab. Patients and Methods: We retrospectively screened 118 advanced NS-NSCLC patients who were treated with pemetrexed plus platinum derivatives alone (Bev(−)) or with bevacizumab (Bev(+)), and investigated the relationship between expression of TTF-1 and treatment outcomes. Results: Among the 92 TTF-1-positive patients, clinical outcomes in the Bev(+) group were significantly better than those in the Bev(−) group (response rate, 51.4% vs. 27.3%, p=0.027; median progression-free survival, 216 days vs. 137 days, p=0.012). Overall survival in the Bev(+) group tended to be longer than that in the Bev(−) group. However, the addition of bevacizumab to the standard treatment of 26 TTF-1-negative patients offered no clinical benefit. Conclusion: TTF-1 expression may serve as a predictive marker to identify patients who may benefit from the addition of bevacizumab to platinum doublet therapy." @default.
- W2891900934 created "2018-09-27" @default.
- W2891900934 creator A5004948297 @default.
- W2891900934 creator A5019508043 @default.
- W2891900934 creator A5019609240 @default.
- W2891900934 creator A5037639067 @default.
- W2891900934 creator A5048778164 @default.
- W2891900934 creator A5050972585 @default.
- W2891900934 creator A5052311523 @default.
- W2891900934 creator A5054540480 @default.
- W2891900934 creator A5056483654 @default.
- W2891900934 creator A5062245939 @default.
- W2891900934 creator A5069366555 @default.
- W2891900934 creator A5072532654 @default.
- W2891900934 creator A5074171160 @default.
- W2891900934 creator A5087199488 @default.
- W2891900934 date "2018-09-01" @default.
- W2891900934 modified "2023-10-05" @default.
- W2891900934 title "TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer" @default.
- W2891900934 doi "https://doi.org/10.21873/anticanres.12882" @default.
- W2891900934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30194207" @default.
- W2891900934 hasPublicationYear "2018" @default.
- W2891900934 type Work @default.
- W2891900934 sameAs 2891900934 @default.
- W2891900934 citedByCount "13" @default.
- W2891900934 countsByYear W28919009342020 @default.
- W2891900934 countsByYear W28919009342021 @default.
- W2891900934 countsByYear W28919009342022 @default.
- W2891900934 countsByYear W28919009342023 @default.
- W2891900934 crossrefType "journal-article" @default.
- W2891900934 hasAuthorship W2891900934A5004948297 @default.
- W2891900934 hasAuthorship W2891900934A5019508043 @default.
- W2891900934 hasAuthorship W2891900934A5019609240 @default.
- W2891900934 hasAuthorship W2891900934A5037639067 @default.
- W2891900934 hasAuthorship W2891900934A5048778164 @default.
- W2891900934 hasAuthorship W2891900934A5050972585 @default.
- W2891900934 hasAuthorship W2891900934A5052311523 @default.
- W2891900934 hasAuthorship W2891900934A5054540480 @default.
- W2891900934 hasAuthorship W2891900934A5056483654 @default.
- W2891900934 hasAuthorship W2891900934A5062245939 @default.
- W2891900934 hasAuthorship W2891900934A5069366555 @default.
- W2891900934 hasAuthorship W2891900934A5072532654 @default.
- W2891900934 hasAuthorship W2891900934A5074171160 @default.
- W2891900934 hasAuthorship W2891900934A5087199488 @default.
- W2891900934 hasBestOaLocation W28919009341 @default.
- W2891900934 hasConcept C126322002 @default.
- W2891900934 hasConcept C143998085 @default.
- W2891900934 hasConcept C2776256026 @default.
- W2891900934 hasConcept C2776694085 @default.
- W2891900934 hasConcept C2777240266 @default.
- W2891900934 hasConcept C2777802072 @default.
- W2891900934 hasConcept C2778239845 @default.
- W2891900934 hasConcept C71924100 @default.
- W2891900934 hasConceptScore W2891900934C126322002 @default.
- W2891900934 hasConceptScore W2891900934C143998085 @default.
- W2891900934 hasConceptScore W2891900934C2776256026 @default.
- W2891900934 hasConceptScore W2891900934C2776694085 @default.
- W2891900934 hasConceptScore W2891900934C2777240266 @default.
- W2891900934 hasConceptScore W2891900934C2777802072 @default.
- W2891900934 hasConceptScore W2891900934C2778239845 @default.
- W2891900934 hasConceptScore W2891900934C71924100 @default.
- W2891900934 hasIssue "9" @default.
- W2891900934 hasLocation W28919009341 @default.
- W2891900934 hasLocation W28919009342 @default.
- W2891900934 hasOpenAccess W2891900934 @default.
- W2891900934 hasPrimaryLocation W28919009341 @default.
- W2891900934 hasRelatedWork W2013563962 @default.
- W2891900934 hasRelatedWork W2020996031 @default.
- W2891900934 hasRelatedWork W2045061462 @default.
- W2891900934 hasRelatedWork W2069435948 @default.
- W2891900934 hasRelatedWork W2774698410 @default.
- W2891900934 hasRelatedWork W3011176692 @default.
- W2891900934 hasRelatedWork W3029430426 @default.
- W2891900934 hasRelatedWork W3192958152 @default.
- W2891900934 hasRelatedWork W3201348732 @default.
- W2891900934 hasRelatedWork W4234162845 @default.
- W2891900934 hasVolume "38" @default.
- W2891900934 isParatext "false" @default.
- W2891900934 isRetracted "false" @default.
- W2891900934 magId "2891900934" @default.
- W2891900934 workType "article" @default.